DEA Finalizes Two Telemedicine Rules, Proposes Expanded Prescribing via Special Registrations
January 24, 2025 at 14:58:40 ET
The DEA Jan. 16 announced three rules to make permanent some of the temporary flexibilities established for the remote prescribing of controlled substances via telemedicine during the COVID-19 public health emergency.
The rules apply where a patient has never been seen by the medical practitioner and the patient is being prescribed controlled substances.
The agency’s goal, said DE... Read More
